The A/Japan/57 influenza hemagglutinin (HA) peptide HA 128-145, when bound by human histocompatibility leukocyte antigen-DRw11 cells, is recognized by the human CD4+ T cell clone V1. A rabbit antiserum has been raised against HA 128-145 which recognizes not only the free peptide, but also the HA 128-145/DRw11 complex on a solid matrix, in solution, or on the surface of viable cells. The detection of these complexes on viable cells was shown to be class II specific, DRw11 restricted, and commensurate with the level of DRw11 expression. The identity of DRw11 as the cell surface molecule binding HA 128-145 was confirmed by immunoprecipitation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and tryptic peptide mapping. Using this antiserum, HA 128-145/DRw11 complexes could be detected on the cell surface as soon as 30 min after the peptide was added, and increased up to 24 h. Dissociation kinetics showed these complexes were long-lived, with a half-life of approximately 14 h. This anti-HA peptide antiserum represents the first direct means of studying antigenic peptide-human leukocyte antigen class II complexes on the surface ofliving cells without the addition of a nonamino acid moiety to the peptide. The properties of this antiserum thus provide the potential to study naturally processed antigenic peptides as well as the mechanism of processing itself in a physiologically relevant system . T he immune response of CD4+ T cells is thought to be triggered by immunogenic MHC class II moleculepeptide complexes present on the surface of APC's (1-5). Previous reports have demonstrated in vitro association of peptide antigen with purified class II molecules (5-10), and proliferation of cloned T cells exposed to these complexes (6, 11) .
T he immune response of CD4+ T cells is thought to be triggered by immunogenic MHC class II moleculepeptide complexes present on the surface of APC's (1) (2) (3) (4) (5) . Previous reports have demonstrated in vitro association of peptide antigen with purified class II molecules (5) (6) (7) (8) (9) (10) , and proliferation of cloned T cells exposed to these complexes (6, 11) .
While antigen-specific T cells have been useful for qualitatively demonstrating the presence of such complexes, the low number of surface peptide-class II complexes needed to activate a T cell, and the all-or-none nature of the recognition event have made such assays less useful for studying the kinetics and nature ofpeptide-class II binding (12) (13) (14) . Studies of APC antigen processing and class II loading have been hampered by the inability to directly detect peptide bound in the antigen-binding groove ofthese molecules on the surface ofintact cells. Whole cell binding assays using radiolabelled peptide antigen have been plagued by nonspecific uptake of radiolabel into the cells . Those studies which promote metabolic antigen-processing have suffered from unacceptably high levels of nonspecific binding which have made it difficult to separately study the complexes of peptide antigen bound to surface class II molecules . Similar studies done under conditions which block APC intracellular antigen uptake and processing have demonstrated a high level of nonspecific cell surface binding and only a low level of binding to class II molecules (7, (15) (16) (17) (18) (19) (20) .
A series of rather elegant studies using biotinylated peptides and a fluorescent-avidin detection system has emerged from the laboratory of J.B. Rothbard, Immunologic Pharmaceutical Corporation (Palo Alto, CA) (12, 21, 22) , allowing valuable insights into the association of immunogenic peptides with cell surface class II molecules . However, the interpretation of these studies is complicated by the potential ofthe biotin moiety to alter the conformation of the peptide bearing the biotin, or to affect the binding of the peptide to the class II molecule when attached to an amino acid in the MHC-interacting region of the antigen.
An antibody reagent which could detect unmodified peptide-MHC class II complexes on the cell surface would clearly be advantageous, and also has the potential to detect naturally processed peptides derived from intact antigen. A series of studies in the late 1970's and early 1980's initially sought to raise such antisera (17, (23) (24) (25) (26) . Although these studies did raise several antisera capable of binding to free peptide antigen, they were unsuccessful in obtaining binding of peptide to class II after the antisera had bound the peptide, or in demonstrating antisera binding to antigen after antigen uptake onto class II had occurred . Among the possibilities suggested to explain this failure were the denaturation or removal during antigen processing of epitopes on the peptide that are recognized by the antisera, masking of the epitope by the class II molecule, or alteration of the epitope upon binding of peptide to class II (17, 23) .
The human, cytolytic, CD4-positive T cell clone, V1, has been shown to recognize a fragment of hemagglutinin protein from the influenza strain A/Japan/57 (Brown, L.R ., N. Nygard, M.B. Graham, C. Bono, V.L . Braciale, J. Gorka, B.D. Schwartz, and T.J . Braciale, manuscript submitted for publication) . This hemagglutinin peptide includes the amino acid residues 128-145, and is recognized by V1 only in the context HLA of DRw11.
We report here the ability of a rabbit antiserum raised against this influenza hemagglutinin (HA)l peptide to directly detect the complex recognized by the human T cell clone V1, composed of an antigenic HA peptide without any artificial linkage element and bound to HLA-DRw11 on the surface of an APC.
Materials and Methods
Synthetic Peptides. All peptides used in this study were synthesized on an Applied Biosystems (Foster City, CA) automated solid phase peptide synthesizer. The photoprobe peptide was also made on the Applied Biosystems instrument by incorporating the photoreactive group 4-benzoylbenzoic acid on the e-amine of the N-terminal lysine according to the method of Gorka et al . (27) . The sequences of all peptides used are given in Fig. 1 .
Cell Lines and Clones. The T cell clone VI was generated and maintained as previously described (28) . It is specific for the hemagglutinin peptide encompassing amino acid residues 128-145 (HA 128-145) from influenza strain A/Japan/57 when presented in the context of HLA-DRw11(Brown, L.R ., N. Nygard, M.B. Graham, C. Bono, V.L . Braciale, J. Gorka, B.D. Schwartz, and T.J . Braciale, manuscript submitted for publication) . EBVtransformed B lymphoblastoid cell lines (B-LCL's) GM3104 (DRI/DRI), GM3161 (DR2/DR2), GM3098 (DR3/DR3), and GM3164 (DR4/DR4) were obtained from the Mutant Cell Repository (Coriell Institute for Medical Research, Camden, NJ). The B-LCL Swei (DRw11/ DRw11) was originally obtained from Dr. John Hansen (Fred Hutchinson Cancer Research Center, Seattle, WA), and has been maintained in our laboratory for the past 12 yr. TB-LCL (DR2/ DRw11) was transformed from normal B cells autologous to clone V1 . SJO, a B-LCL prepared from a patient with the class II-negative phenotype, bare lymphocyte syndrome was the generous gift of 1 Abbreviations used in this paper: B-LCL, B lymphoblastoid cell line ; HA, influenza hemagglutinin; PP, photoprobe peptide .
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Human Leukocyte Antigen Class II-HA Peptide Complex Dr . Jack Gorski (Milwaukee Blood Center, Milwaukee, WI). The murine L cell transfectants bearing DRw11, DRw52, DQw7, or DPw4 were the generous gift of Dr. Robert Karr (VA Medical Center, Iowa City, IA).
T Cell S'Cr Release Cytotoxicity Assay. The "Cr-release cytotoxicity assay was performed as previously described (28) .
ceHA Peptide Antiserum. ceHAP rabbit antiserum was prepared as in references 29 and 30 with the following modifications. 5 mg of HA 128-145 photoprobe peptide (HA 128-145 PP, Fig. 1 ) was mixed with 4.5 mg of BSA or KLH and exposed to 362 nm UV light at a distance of 2 cm for 3 h at which time >65% of HA 128-145 PP was conjugated to the protein. 350 Ag of peptide-protein conjugate in 200 Al PBS was emulsified in 500 Al CFA, and used to immunize rabbits by s.c. injection at three sites. The rabbits were boosted at 2 and 4 wk by injection of 350 Pg of peptide-protein conjugate in 500 Al IFA, and were bled 1 wk thereafter. Negative control antiserum was prepared in an identical fashion with irrelevant DN10 peptide (Fig . 1) .
Mouse Monoclonal Antibodies. The hybridoma producing the anti-DR framework antibody L243 was obtained from the American Type Culture Collection (Rockville, MD). The L243 was affinity-purified using protein A-Sepharose, and used at a concentration of 0.4 mg/ml for whole cell lysate immunoprecipitation . Nunc #439454 microtiter plate wells (Nunc, Inc., Naperville, IL) were coated with peptide or protein overnight at 4°C and washed with PBS/1% BSA. Where indicated, the wells containing platebound protein were then incubated with 2 Rg peptide in 100 Al PBS for 3 h at room temperature and rewashed in PBS/1% BSA. 100 Al of rabbit serum diluted 1/100 in PBS/1% BSA were added to each well, the incubation continued for 45 min at room temperature, and the wells then washed. The second antibody added was 100 Al of a 1/1000 dilution of alkaline phosphatase-conjugated goat anti-rabbit IgG (Sigma Chemical Co., St . Louis, MO) followed by a 45 min incubation at room temperature . After washing, the ELISA was developed by addition to each plate well of 100 JAI of a 1 mg/ml substrate, p-nitrophenyl disodium phosphate, (Sigma #104-105 ; Sigma Chemical Co.) . Following a 1 h room temperature incubation, the OD was read at 410 nm on a Dynatech MR700 ELISA plate reader.
Fluorescence-Activated Cell Sorter Assay with ceHAR 106 indicated cells were incubated for 24 h at 37°C in 7% C02 atmosphere in 1 ml culture medium containing 5% dialyzed FCS and 21 AM of the indicated peptide. The cells were washed twice in PBS/1% FCS and resuspended at 5 x 107/ml in wash buffer. Equal aliquots of peptide-pulsed cells were incubated for 20 min at 4°C with 100 AI of 1/100 dilution of preimmune rabbit serum or immune rabbit otHA peptide antiserum, or the indicated mAb in PBS/1% FCS. After incubation the cell aliquots were washed in PBS/1% FCS, and then incubated in 100 Al of FITC-conjugated goat anti-rabbit IgG (Fisher Biotech #OB1400; Fisher Scientific, St . Louis, MO) for rabbit sera, 100 j.al of FITC-conjugated goat anti-mouse IgG (Fisher Biotech #OB1420-FITC) for unconjugated murine mAb, or no secondary reagent for FITC-conjugated mAb. After rewashing twice at 4°C in PBS/1% FCS, cells were fixed in 200 Fx1 1% formaldehyde and stored at 4°C until FRCS analysis. Cell pellets were brought up in 200 /.Al saline and run on a FACS® Analyzer (Becton Dickinson and Co.), counting 10,000 cells/plot.
Immunoprecipitations of Radiolabeled HA (128-145)PP-Pulsed Swei Cell Lysates. 70 x 106 Swei cells were incubated in 35 ml culture medium containing 5% FCS and 250 Ag "'I-labeled HA 128-145 photoprobe peptide. The peptide was labeled by the iodobead method (Pierce Scientific, Rockford, IL) to a specific activity of 18 .7 uCi/Ag. After incubation for 24 h at 37°C, the cells were washed twice in cold PBS and exposed to 350 tun wavelength UV light at 4°C for 1 h. The cells were washed two more times in cold PBS and lysed in 1 ml cold PBS containing 1% NP-40, 50 ug/ml N-tosyl-L-phenylalanine chloromethyl ketone (TPCK), 50 Ag/ml Nap-tosyl-L-lysine chloromethyl ketone (TLCK), and 200 Ag/ml PMSF. The lysate was centrifuged at 13,250 RPM for 15 min, and pre-cleared with 100 tt,l packed protein ASepharose (Pharmacia, Uppsala, Sweden) for 30 min at 4°C with agitation. After centrifugation, the supernatant was divided into equal aliquots, and 50 Fd of NRS, ciHAP, MKD6, OKDR, or L243 were added. Overnight incubation at 4°C was followed by addition of 100 ul packed protein A-Sepharose for 30 min at 4°C with agitation every 5 min. After centrifugation the pellets were washed three times with cold 0.25% NP-40, then boiled for 2 min in 165 141 2% mercaptoethanol SDS elution buffer and run on an 11% SDS-PAGE gel. After fixation and drying, the gel was subjected to autoradiography.
Trypsin Digestion and Peptide Mapping. The proteins to be compared were eluted from an excised piece of gel, subjected to trypsin digestion, and peptide mapped as previously described (33) . recognizes a specific 18-amino acid fragment (residues 128-145) of HA from influenza strain A/Japan/57, when presented on HLA-DRw11 APC's (Brown, L.R., N. Nygard, M.B. Graham, C. Bono, V.L. Braciale, J. Gorka, B.D . Schwartz, and T.J . Braciale, manuscript submitted for publication) . We modified this peptide by substituting tyrosine for valine at position 129 to allow I'll-radioiodination in some experiments, and for other experiments by adding a photoreactive side chain residue, 4-benzoylbenzoic acid to the e-amine of the N-terminal lysine (Fig. 1) . The recognition by clone Vl of the altered synthetic HA peptide (HA 128-145) was found to be identical to that of the native unmodified HA peptide when presented on DRw11 APC's (Fig. 2) . In addition, the HA 128-145 photoprobe peptide (PP) (Fig. 1 ) was recognized equally well by clone V1 when presented on HLA-DRw11 cells (data not shown) . Rabbit Antiserum oiHAP Recognizes Both Free HA Peptide and HA Peptide Bound to DRw11. When assayed by ELISA, rabbit antisera otHAP raised against HA 128-145 PP coupled to BSA or KLH did not react with the irrelevant peptide DN10 nor with affinity-purified DRw11 class II molecules alone (Fig . 3, A and B) . However, the antisera did react with plate-bound HA 128-145 at a titer >1 :200,000, (Fig. 3 A) as well as with complexes formed when plate-bound, affinitypurified HLADRw11 molecules were first exposed to soluble HA 128-145 (Fig. 3 B) . In contrast, these antisera did not recognize plate-bound DRw11 molecules were first exposed to soluble HA 128-145 (Fig . 3 B) . In contrast, these antisera did not recognize plate-bound DRw11 molecules exposed to an irrelevant peptide, nor plate-bound BSA incubated with HA 128-145 . These results indicate that HA 128-145 bound to the plate-bound DRw11 molecules, and that the antisera were recognizing HA 128-145 complexed to DRw11 . Because the antisera raised against the BSA and KLH-conjugated HA 128-145 yielded similar results, only the experiments using antiserum raised against HA 128-145 conjugated to BSA (denoted ciHAP1 in Fig. 3 and aHAP in subsequent figures) are presented . ciHAP Detects HA 128-145 Uptake Onto Intact DRw11-Expressing B Cells by FACS. To determine if ciHAP could detect HA 128-145 on the surface of a DRw11-expressing APC, cell flow cytometry (FACS) analysis was done (Fig .  4 A) . The homozygous DRw11 BLCL Swei was incubated with no peptide (Fig. 4 A, panel b) or with HA 128-145 (Fig.  4 A, panel c) for 24 h, was reacted with allAP, stained with FITC-conjugated goat anti-rabbit immunoglobulin, and analyzed by FACS. A class II negative, bare lymphocyte syndrome BLCL, SJO, was similarly treated (Fig. 4 A, panel a) . A significant fluorescence shift was seen with otHAP for the HA peptide-pulsed, class II-positive Swei cells (Fig. 4 A, panel  c) but not for the HA peptide-pulsed SJO cells, nor for the Swei cells not exposed to HA peptide . In addition otHAP did not react with Swei cells which had been exposed to the 24 irrelevant DN10 peptide (data not shown) . These results suggest that HA peptide uptake is specific for class II-expressing cells, and that oeHAP can detect the peptide on such whole, living cells directly by FACS assay. The Surface Expression ofHA 128-145 on Antigen-Presenting Cells is DRwil-Restricted Homozygous BLCLs bearing DR1, DR2, DR3, or DR4, and one heterozygous (DR2,w11) BLCL (TBLCL) were incubated sequentially with non-photoprobe HA 128-145, with ciHAP, and with FITC-goat anti-rabbit antiserum . The marked fluorescence shift observed with Swei cells (Fig . 4 A, panel c) was not seen with SJO, nor with any of the other homozygous HLA class II-expressing lines studied (Fig. 4 A, panels e-h) , indicating allelic specificity in the formation of the DRw11-HA 128-145 complex . The DR2,w11-positive TBLCL showed approximately half the fluorescence obtained with Swei cells when both were stained with ciHAP (Fig. 4 A, panels d and c) and with the antiDRw11 mAb SFR3-DR5 for DR expression (Fig . 4 B, To further demonstrate this association an immunoprecipitation experiment was performed. Swei cells were incubated with 125 1-labeled HA 128-145 PP for 24 h at 37°C. The cells were washed, exposed to UV light to form covalent class IIphotoprobe linkages, and were then detergent-lysed. HA 128-145 PP-conjugated molecular complexes were immunoprecipitated from whole cell lysates with ciHAP or anti-DR mAb OKDR and Sepharose-linked protein A, and were then analyzed on SDS-PAGE under reducing conditions (Fig . 5 A) . Although we had initially expected HA 128-145 PP to be associated with a number of cell components, autoradiographs demonstrated only two bands at -36 kD and 28 kD, corresponding to the expected approximate sizes of the -2 .3 kD HA 128-145 photoprobe peptide bound to DRw11 a SDS-PAGE (Fig. 5 B) , the corresponding bands (arrow heads) were excised, eluted, and subjected to trypsin digestion. Comparative tryptic peptide analysis indicated that the HA 128-145 PP-conjugated proteins were indeed the DRw11 a and (3 chains (Fig . 5 C and D) . DRwll-Binding ofHA 128-145 Inhibits L243 Binding FACS analysis of Swei cells incubated in the absence or presence of HA 128-145 before staining with FITC-conjugated L243 indicated that preincubation with HA 128-145 inhibited recognition of DRw11 by L243 and then protein A-Sepharose (Fig. 6 A) . This finding was confirmed by immunoprecipitation . When the lysate of Swei cells photoconjugated with 125 1-labeled HA 128-145 PP was reacted with L243, (Fig. 6  B) no bands were seen, despite the presence of bands with allAP (Fig. 6 B) , and with OKDR (Fig. 5 A) . These results indicated that the epitope recognized by L243 is either located near the DRw11 antigen-binding site or is conformationally altered when HA 128-145 is bound.
The observation that uHAP was capable ofdirectly recognizing HA 128-145/DRwll complexes on the surface of living APC's indicated that ciHAP presented the most direct means to date of studying antigen-class 11 interaction in a human T cell/antigen/APC system and allowed functional studies of MHC-peptide interaction with viable APCs.
Kinetics of Association of HA 128-145 with HLA-DRw11. Swei cells were incubated with HA 128-145 for increasing time periods, then stained with FITC-goat anti-rabbit IgG, and analyzed by FACS. HA 128-145/DRw11 complexes were detectable within 30 min and increased for approximately 20-24 h with a 50% saturation time of 5 1/2 h (Fig. 7) . No further increase was seen at 48 h. 
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Kinetics of Disappearance of HA 128-145/DRw11 Complexes. Swei cells were incubated with HA 128-145 for 24 h, placed in HA peptide-free media for increasing time periods, and then assayed by FACS for cell surface HA peptide. A prolonged half-life of approximately 14 h was seen for the surface HA 128-145/DRwll complexes (Fig. 8) , indicating that the complexes are relatively long-lived.
Discussion
The immunogenic complex composed of the hemagglutinin peptide HA 128-145 and HLADRw11 is recognized by the cytotoxic CD4+ T cell clone V1. The experiments presented here provide direct biochemical evidence that the same cell surface immunogenic complex can be detected by an antiserum produced against the peptide . This antiserum thus provides the first direct means of studying MHC class II-peptide complexes in which the peptide has not been modified by the addition of any non-amino acid moiety. The absence of any such non-amino acid moiety on the peptide eliminates the possibilities that the affinity ofthe peptide for class II or the recognition of the complex by a T cell will in any way be altered .
Antibody recognition of cell surface complexes ofHA 128-145/DRw11 complexes was validated by demonstrating antibody binding to DRw11 positive B-LCL's exposed to HA 128-145, but not to DRw11 negative cells similarly exposed. Antibody also bound to DRw11 positive L cell transfectants incubated with HA 128-145, but not to parental untransfected L cells nor to L cells bearing a different class II molecule that were similarly incubated with peptide. In addition, the number ofcomplexes detected was always commensurate with the level of DR expression.
The complex could also be detected in lysates ofcells both when the peptide was unmodified, and after the DRw11 a and ß chain peptide interactions had been stabilized by photoconjugation with a photoreactive moiety attached to the peptide. The identity of the DRw11 molecule bound to the peptide under these conditions was confirmed through immunoprecipitation of the complexes by both ceHAP and the anti-DR mAb OKDR, by mobility on SDS-polyacrylamide gels, and by tryptic peptide mapping.
Our ability to detect unmodified peptide-class II complexes on the cell surface with anti-peptide antibody successfully for the first time most likely depends on at least three parameters which are optimized in our system . First, Swei cells have between 5 x 105 and 106 DRw11 surface molecules/cell (J. Pollack, Washington University, St. Louis, MO, unpublished observations), presenting a large number ofpotential binding sites for the HA peptide. Second, dose-response curves suggest a high affinity between HA 128-145 and DRw11 . Third, an epitope on HA 128-145 recognized by the ctHAP antiserum remains available to the antiserum when the peptide is bound in the DRw11 antigen-binding cleft . It is possible that in other systems these conditions were not coincident.
The ability of ctHAP to recognize the HLADRw11/HA 128-145 complex without the addition of non-amino acid moieties to the peptide allows delineation of the kinetics of formation and disappearance of complexes without concerns that the kinetics may be affected by the presence of a foreign element . In addition, because detection does not depend on the presence of a foreign element, the antiserum detection system for the first time presents the potential for following the kinetics of complex formation during intracellular uptake and antigen processing.
Initial kinetic characterization has been accomplished using the HA 128-145 peptide and detection of cell surface complexes by FACS. The association curve of HA 128-145/DRw11 complexes (Fig. 7) shows an appearance of the complex by 30 min that is consistent with previous reports (34, 35) . The continued complex accumulation to 24 h is longer than that previously reported by Ceppellini et al. (34) for living APC's and is consistent with the report of Busch et al. (12, 22) , who showed a lack of surface peptide,-class II saturation after 16 h of APC antigen incubation using a biotinylated HA 307-319 peptide on DR1-expressing cells. Studies of peptide saturation using solubilized, purified class II protein have also demonstrated a slow accumulation of the complex peaking at extended intervals of from 6 to 50 h (7, 8, 34) . The very rapid plateau in binding of radiolabeled peptide on whole B-LCL's reported by Ceppellini et al. (34) may be a reflection of cell peptide internalization with the inability of the radiolabel assay to separate surface from internal peptide uptake .
The dissociation plot of Fig. 8 indicates that the cell surface complex of HA 128-145 and DRw11 class II is very stable . The stability of these complexes has been shown previously with purified class 11 molecules (5, 8, 12, 22, 36) , but the half-life of these complexes on intact cells has not been as well characterized (12, 13, 22, 34, 36) .
The precise epitope(s) recognized by the ciHAP antiserum when the HA 128-145 peptide is bound in the DRw11 cleft has not yet been identified, and this identification may have implications for recognition of the naturally processed peptide. While the size of the naturally processed peptide bound References to a class I molecule has recently been determined (37) , no similar determination has yet been made for peptides bound to class II molecules. However, preliminary studies demonstrating that the aiHAP antiserum blocks V1 recognition of DRw11 positive target cells exposed to HA 128-145 (Mary Beth Graham, Washington University School of Medicine, St. Louis, MO, unpublished results) underscore the physiologic relevance ofthe antibody recognition, and suggest that cxHAP may well recognize the naturally processed peptide.
A number of technical difficulties have prevented demonstrating whether or not otHAP can recognize naturallyprocessed A/Japan/57 hemagglutinin on DRw11-expressing cells using cytofluorometry. The exposed position ofHA 128-145 on the A/Japan/57 virion allows aHAP to detect the intact virion . The inability to clear unprocessed virions either enzymatically or by natural turnover from the membranes of target cells pulsed with UVtreated virus has resulted in high levels of ciHAP staining by the FRCS assay even on non-DRw11 APC's. Intact hemagglutinin and a truncated 45 amino acid HA peptide containing the 128-145 epitope also bind nonspecifically to non-DRw11 cells and are also detected by c iHAP, again resulting in high background. Distinguishing the DRw11-associated HA peptide surface staining from this high background level has not been possible. Studies are currently underway using HA peptides coupled to transferrin to circumvent these difficulties.
The ability for the first time to directly detect peptide-MHC class II surface complexes on APC's with ciHA peptide antiserum allows a number of studies that previously have been difficult or impossible to perform . Indeed, it may be possible to characterize the naturally processed peptide and the intracellular compartments in which naturally processed peptide interacts with MHC class II antigens. These studies are currently underway, and should provide new opportunities for extending our knowledge of human MHC class II function.
